Latest Drug development biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Abren la puerta para utilizar una nueva vía para el desarrollo de medicamentos

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

12 months ago
beta arrestina, proteínas G

Un equipo internacional, liderado por la Universidad de Birmingham, en el Reino Unido, con participación del Instituto Hospital del Mar de Investigaciones Médicas, ha analizado cómo una proteína e...

Almirall: Hasta el 73% de los pacientes con dermatitis atópica tratados con lebrikizumab logran un aclaramiento de la piel de la cara o las manos

by Asebio

12 months ago
lebrikizumab, Almirall, ADvocate y ADhere, dermatitis

Almirall ha anunciado recientemente los resultados de un análisis secundario del programa en fase III (estudios ADvocate y ADhere) que ha demostrado que los pacientes tratados con lebrikizumab mejora...

ORYZON reports financial results and corporate update for quarter ended March 31, 2023

by Oryzon Genomics

12 months ago
Iadademstat, Vafidemstat, Oryzon

Oryzon Genomics, S.A. a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the first ...

Palobiofarma announces the enrolment of the first three patients in the clinical study investigating the effects of its novel compound PBF-999 for the treatment of Prader-Willi Syndrome

by Palobiofarma

12 months ago
Prader-Willi Syndrome (PWS, PBF-999

Palobiofarma S.L., a biopharmaceutical company dedicated to the discovery and development of innovative drugs, has enrolled the first three patients in a clinical study to investigate the potential of...

ORYZON to present trial in progress Phase Ib FRIDA study at the upcoming 2023 ASCO annual meeting

by Oryzon Genomics

12 months ago
Iadademstat in combination with gilteritinib, mutated FLT3 relapsed/refractory acute myeloid leukemia, Oryzon

Oryzon today announced the presentation of the trial in progress (TIP) FRIDA poster entitled Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myelo...

Una nueva vía para el tratamiento del cáncer de hígado infantil

by CIBEREHD-Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

12 months ago
hepatoblastoma, xentuzumab, proteína IGF2

Han descubierto una posible vía para el tratamiento de los pacientes con hepatoblastoma, combinando la quimioterapia habitual con un fármaco actualmente en ensayos clínicos, el xentuzumab

A Spanish team presents the first pharmacological treatment able to improve cardiac function in stiff-heart syndrome

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

11 months ago
Transthyretin-related cardiac amyloidosis, amyloid protein, Tafamidis

The study represents a major advance in the treatment of the disease. Although currently available treatments effectively prevent the accumulation of more amyloid fibrils and delay disease progression...

Clinical trials: the patient's perspective

by Sermes CRO

11 months ago
Clinical trials

From the beginning of the development of any drug until it is available to patients and health professionals, its safety and efficacy must be studied and demonstrated. That is exactly what clinical t...

Pacientes con Parkinson, esquizofrenia, EPOC, diabetes o enfermedades raras, un pequeño ejemplo de quiénes se pueden beneficiar de la innovación incremental de los medicamentos

by Farmaindustria

11 months ago
medicina individualizada, innovación incremental

A veces, la innovación farmacéutica se basa en una nueva forma de aplicación, con efectos más rápidos de actuación; en una mejora en la composición, que reduce los efectos adversos, o en un nue...

CRG teams up with Almirall to develop new preclinical models for non-melanoma skin cancer

by Centre for Genomic Regulation

11 months ago
non-melanoma skin cancer (NMSC), Almirall, Centre for Genomic Regulation (CRG)

This new collaboration comes from a call from AlmirallShare, the company's open innovation platform, to find innovative therapies for skin diseases

ORYZON to present positive preclinical efficacy data of ORY-4001 in Charcot-Marie-Tooth (CMT) disease at the 2023 Peripheral Nerve Society (PNS) Annual Meeting

by Oryzon Genomics

11 months ago
ORY-4001, Charcot-Marie-Tooth (CMT) disease

Oryzon announced today that it will present positive preclinical efficacy data of ORY-4001 in a CMT model at the 2023 Peripheral Nerve Society (PNS) Annual Meeting, which will be held June 17-20 at th...

International funding for IRBLleida's innovative Friedreich's Ataxia project

by IRB Lleida. Institut de Recerca Biomèdica

11 months ago
Friedreich's ataxia disase, frataxin

The US association FARA (Friedreich's Ataxia Research Alliance) has awarded a grant of 85,000 US dollars a project led by Jordi Tamarit Sumalla, professor at the University of Lleida and researcher i...